Evidence map›Paper›PMID 32702746›Full record

ArticleEuropean heart journal2020

Genetic variability in the absorption of dietary sterols affects the risk of coronary artery disease.

Anna Helgadottir, Gudmar Thorleifsson, Kristjan F Alexandersson, Vinicius Tragante, Margret Thorsteinsdottir, Finnur F Eiriksson, Solveig Gretarsdottir, Eythór Björnsson, Olafur Magnusson, Gardar Sveinbjornsson and 33 more

Open access · bronzeAbstract read
In one paragraph

Article in European heart journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
12.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

43 authors at 13 institutions in 4 countries.

Anna HelgadottirdeCODE genetics/Amgen, Inc., Sturlugata 8, 102 Reykjavik, Iceland.
Gudmar ThorleifssondeCODE genetics/Amgen, Inc., Sturlugata 8, 102 Reykjavik, Iceland.
Kristjan F AlexanderssondeCODE genetics/Amgen, Inc., Sturlugata 8, 102 Reykjavik, Iceland.
Vinicius TragantedeCODE genetics/Amgen, Inc., Sturlugata 8, 102 Reykjavik, Iceland.
Margret ThorsteinsdottirArcticMass, Sturlugata 8, 102 Reykjavik, Iceland.
Finnur F EirikssonArcticMass, Sturlugata 8, 102 Reykjavik, Iceland.
Solveig GretarsdottirdeCODE genetics/Amgen, Inc., Sturlugata 8, 102 Reykjavik, Iceland.
Eythór BjörnssondeCODE genetics/Amgen, Inc., Sturlugata 8, 102 Reykjavik, Iceland.
Olafur MagnussondeCODE genetics/Amgen, Inc., Sturlugata 8, 102 Reykjavik, Iceland.
Gardar SveinbjornssondeCODE genetics/Amgen, Inc., Sturlugata 8, 102 Reykjavik, Iceland.
Ingileif JonsdottirdeCODE genetics/Amgen, Inc., Sturlugata 8, 102 Reykjavik, Iceland.
Valgerdur SteinthorsdottirdeCODE genetics/Amgen, Inc., Sturlugata 8, 102 Reykjavik, Iceland.
Egil FerkingstaddeCODE genetics/Amgen, Inc., Sturlugata 8, 102 Reykjavik, Iceland.
Brynjar Ö JenssondeCODE genetics/Amgen, Inc., Sturlugata 8, 102 Reykjavik, Iceland.
Hreinn StefanssondeCODE genetics/Amgen, Inc., Sturlugata 8, 102 Reykjavik, Iceland.
Isleifur OlafssonDepartment of Clinical Biochemistry, Landspitali -National University Hospital of Iceland, Hringbraut, 101 Reykjavik, Iceland.
Alex H ChristensenHerlev-Gentofte Hospital, Copenhagen University Hospital, Gentofte Hospitalsvej 1, 2900 Hellerup, Denmark.
Christian Torp-PedersenDepartment of Cardiology and Clinical Research, Nordsjaellands Hospital, Dyrehavevej 29, 3400 Hillerød, Denmark.
Lars KøberThe Capital Region's Unit of Inherited Cardiac Diseases, Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark.
Ole B PedersenDepartment of Clinical Immunology, Næstved Hospital, Ringstedgade 61, 4700 Næstved, Denmark.
Christian ErikstrupDepartment of Clinical Immunology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus, Denmark.
Erik SørensenDepartment of Clinical Immunology, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, 2100 Copenhagen, Denmark.
Søren BrunakTranslational Disease Systems Biology, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark.
Karina BanasikTranslational Disease Systems Biology, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark.
Thomas F HansenTranslational Disease Systems Biology, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark.
Mette NyegaardDepartment of Biomedicine, Aarhus University, Høegh-Guldbergs Gade 10, 8000 Aarhus, Denmark.
Gudmundur I EyjolfsssonThe Laboratory in Mjodd, Thonglabakki 6, 109 Reykjavik, Iceland.
Olof SigurdardottirDepartment of Clinical Biochemistry, Akureyri Hospital, Eyrarlandsvegur, 600 Akureyri, Iceland.
Bjorn L ThorarinssonDepartment of Neurology, Landspitali - National University Hospital of Iceland, Hringbraut, 101 Reykjavik, Iceland.
Stefan E MatthiassonLaekning, Medical Clinics, Lágmúli 5, 108 Reykjavik, Iceland.
Thora SteingrimsdottirFaculty of Medicine, University of Iceland, Vatnsmýrarvegur, 101 Reykjavik, Iceland.
Einar S BjornssonDepartment of Internal Medicine, Landspitali - National University Hospital of Iceland, 101 Reykjavik, Iceland.
Ragnar DanielsenDivision of Cardiology, Department of Internal Medicine, Landspitali - National University Hospital of Iceland, Hringbraut, 101 Reykjavik, Iceland.
Folkert W AsselbergsDepartment of Cardiology, Division Heart & Lungs, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, the Netherlands.
David O ArnardeCODE genetics/Amgen, Inc., Sturlugata 8, 102 Reykjavik, Iceland.
Henrik UllumDepartment of Clinical Immunology, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, 2100 Copenhagen, Denmark.
Henning BundgaardThe Capital Region's Unit of Inherited Cardiac Diseases, Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark.
Patrick SulemdeCODE genetics/Amgen, Inc., Sturlugata 8, 102 Reykjavik, Iceland.
Unnur ThorsteinsdottirdeCODE genetics/Amgen, Inc., Sturlugata 8, 102 Reykjavik, Iceland.
Gudmundur ThorgeirssondeCODE genetics/Amgen, Inc., Sturlugata 8, 102 Reykjavik, Iceland.
Hilma HolmdeCODE genetics/Amgen, Inc., Sturlugata 8, 102 Reykjavik, Iceland.
Daniel F GudbjartssondeCODE genetics/Amgen, Inc., Sturlugata 8, 102 Reykjavik, Iceland.
Kari StefanssondeCODE genetics/Amgen, Inc., Sturlugata 8, 102 Reykjavik, Iceland.
deCODE Genetics (Iceland) · ISCopenhagen University Hospital · DKNational University Hospital of Iceland · ISUniversity of Copenhagen · DKUniversity of Iceland · ISAalborg University Hospital · DKAarhus University · DKAarhus University Hospital · DKAkureyri Hospital · ISGentofte Hospital · DKIcelandic Transport Authority · ISRingsted Sygehus · DKUtrecht University · NL

Funding

Medical Research Council MC_PC_17228Medical Research Council MC_QA137853
6 · The paper itself

Abstract

aimsTo explore whether variability in dietary cholesterol and phytosterol absorption impacts the risk of coronary artery disease (CAD) using as instruments sequence variants in the ABCG5/8 genes, key regulators of intestinal absorption of dietary sterols. METHODS AND

resultsWe examined the effects of ABCG5/8 variants on non-high-density lipoprotein (non-HDL) cholesterol (N up to 610 532) and phytosterol levels (N = 3039) and the risk of CAD in Iceland, Denmark, and the UK Biobank (105 490 cases and 844 025 controls). We used genetic scores for non-HDL cholesterol to determine whether ABCG5/8 variants confer greater risk of CAD than predicted by their effect on non-HDL cholesterol. We identified nine rare ABCG5/8 coding variants with substantial impact on non-HDL cholesterol. Carriers have elevated phytosterol levels and are at increased risk of CAD. Consistent with impact on ABCG5/8 transporter function in hepatocytes, eight rare ABCG5/8 variants associate with gallstones. A genetic score of ABCG5/8 variants predicting 1 mmol/L increase in non-HDL cholesterol associates with two-fold increase in CAD risk [odds ratio (OR) = 2.01, 95% confidence interval (CI) 1.75-2.31, P = 9.8 × 10-23] compared with a 54% increase in CAD risk (OR = 1.54, 95% CI 1.49-1.59, P = 1.1 × 10-154) associated with a score of other non-HDL cholesterol variants predicting the same increase in non-HDL cholesterol (P for difference in effects = 2.4 × 10-4).

conclusionsGenetic variation in cholesterol absorption affects levels of circulating non-HDL cholesterol and risk of CAD. Our results indicate that both dietary cholesterol and phytosterols contribute directly to atherogenesis.

Indexed as

Coronary Artery DiseasePhytosterolsATP Binding Cassette Transporter, Subfamily G, Member 5HumansIcelandSterolsATP Binding Cassette Transporter, Subfamily G, Member 5PhytosterolsSterolsABCG5/8AbsorptionDietary cholesterolGeneticsPhytosterols

Identifiers

PMID32702746
PMCPMC7377579
OpenAlexW3044582006

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.